+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Parenteral PrEP Market - Global Forecast 2026-2032- Product Image
Parenteral PrEP Market - Global Forecast 2026-2032- Product Image
Sale

Parenteral PrEP Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118071
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Parenteral PrEP Market is projected to reach USD 490.36 Million in 2026. It is expected to continue growing at a CAGR of 13.21%, reaching USD 1.03 Billion by 2032.

Parenteral PrEP: Executive Summary and Strategic Context

Parenteral pre-exposure prophylaxis (PrEP) refers to long-acting or injectable medicines used to prevent HIV acquisition before potential exposure. Its strategic importance lies in extending prevention beyond daily oral regimens, particularly for people who experience adherence challenges, stigma, privacy concerns, or difficulty accessing frequent refills. Adoption is shaped by clinical evidence, regulatory decisions, delivery capacity, affordability, diagnostic infrastructure, and the ability of health systems to maintain follow-up care.

Long-Acting Prevention Is Reshaping HIV Service Delivery

The prevention landscape is shifting from medication access alone toward differentiated, person-centered delivery. Injectable options can reduce the need for daily pill-taking, but they introduce requirements for trained providers, appointment tracking, injection supplies, cold-chain or storage management where applicable, and timely testing before administration. Successful implementation therefore depends on integrating PrEP with HIV testing, sexual-health services, primary care, community outreach, and robust systems for managing missed visits and transitions between products.

Artificial Intelligence Strengthens Identification, Adherence, and Operations

Artificial intelligence can support parenteral PrEP programs by identifying individuals who may benefit from prevention, improving appointment reminders, optimizing clinic scheduling, and flagging follow-up gaps. Analytical tools may also help interpret service-utilization patterns and target outreach, provided they are validated and used with appropriate safeguards. AI does not replace HIV testing, clinical judgment, informed consent, or pharmacovigilance. Privacy protection, bias monitoring, explainability, cybersecurity, and equitable access are essential when applying these tools to sensitive health data.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America is positioned to emphasize integration with established HIV-prevention services, insurance or public-payer coverage, and access for populations facing adherence or stigma barriers. Latin America’s priorities include procurement, decentralised delivery, provider training, and reducing geographic and financial access gaps. Europe must align implementation with national health-system structures, privacy requirements, and varied reimbursement pathways. The Middle East requires culturally responsive services, discreet access, and stronger prevention awareness in settings where stigma can limit care-seeking. Africa’s implementation focus includes community-based delivery, supply continuity, laboratory capacity, and integration with broader HIV programs. Asia-Pacific combines mature systems with highly diverse access conditions, making local regulatory alignment, differentiated delivery, and targeted outreach especially important.

ASEAN, BRICS, EU, G7, GCC, and NATO Members Require Tailored Implementation Models

ASEAN countries may benefit from interoperable procurement and service-learning approaches while preserving national adaptation. BRICS members span very different epidemiological, regulatory, and health-system contexts, so shared evidence generation should be paired with country-specific delivery planning. European Union members can build on coordinated standards while addressing national differences in reimbursement and service organization. G7 members generally have stronger clinical and digital infrastructure but must still address affordability, inequity, and underserved populations. GCC countries can prioritize discreet, high-quality services and workforce development within centralized systems. NATO members represent a broad set of health environments, making common preparedness and procurement discussions useful but insufficient without local implementation plans.

Country-Level Priorities Across Fifteen Key Markets

Australia can focus on equitable access across urban, rural, and remote communities. Brazil should emphasize public-system integration, community outreach, and consistent supply. Canada may prioritize coordination across provincial and territorial delivery models. China’s priorities include regulatory alignment, clinical capacity, and differentiated access pathways. France, Germany, Italy, and Spain need to connect specialist care with primary and community services while navigating national reimbursement structures. India can emphasize scalable delivery, workforce training, and stigma-sensitive outreach. Japan and South Korea may focus on awareness, provider readiness, and discreet prevention services. Mexico can strengthen integration across public and private settings and address geographic disparities. Russia requires careful alignment with national regulation, testing pathways, and prevention-service accessibility. The United Kingdom can build on established sexual-health infrastructure while addressing regional variation. The United States must consider payer fragmentation, continuity of care, and access for populations disproportionately affected by HIV.

Industry Leaders Should Build Delivery Systems Around Continuity, Equity, and Trust

Leaders should design parenteral PrEP programs around the full care pathway rather than the product alone. Priorities include investing in provider education, standardized HIV testing and follow-up protocols, appointment-recall systems, missed-visit management, transparent patient information, and community partnerships. Access strategies should address affordability and reimbursement while supporting delivery outside specialist centers where clinically appropriate. Organizations should monitor initiation, continuation, timely dosing, adverse events, testing completion, and outcomes by geography and population group. AI-enabled tools should be introduced only with governance, human oversight, privacy controls, and evidence that they improve-not widen-access.

Methodology: Evidence-Based Synthesis of Clinical, Policy, and Delivery Factors

This executive summary uses the defined parenteral PrEP market scope and synthesizes established evidence domains relevant to implementation: prevention science, regulatory and guideline considerations, health-system readiness, service-delivery models, access barriers, regional diversity, and digital-health governance. Insights are framed qualitatively and exclude market estimates, market sizing, market shares, forecasts, and company-specific claims. Regional, group, and country observations reflect structural characteristics and implementation considerations rather than unsupported numerical conclusions. Any operational decision should be validated against current national guidelines, regulatory status, local epidemiology, procurement rules, and stakeholder consultation.

The Strategic Test Is Reliable, Inclusive Delivery of Long-Acting HIV Prevention

Parenteral PrEP can broaden HIV-prevention choice when it is embedded in accessible, trusted, and clinically accountable services. Its impact will depend less on availability in isolation than on reliable testing, timely administration, continuity after missed appointments, affordability, and respect for patient preferences. Leaders that combine differentiated care with strong community engagement, equitable financing, responsible data use, and locally adapted implementation will be better positioned to translate long-acting prevention into sustained public-health benefit.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Parenteral PrEP Market, by Product Type
7.1. Introduction
7.2. Implantable Device
7.2.1. Biodegradable Polymers
7.2.2. Non-Biodegradable Polymers
7.3. Long-Acting Injectable
7.3.1. Cabotegravir
7.3.2. Lenacapavir
7.4. Prefilled Syringes
8. Parenteral PrEP Market, by Molecule Type
8.1. Introduction
8.2. Cabotegravir
8.3. Lenacapavir
9. Parenteral PrEP Market, by Distribution Channel
9.1. Introduction
9.2. Direct-To-Patient Programs
9.2.1. Home Delivery
9.2.2. Mail Order
9.3. Hospital Pharmacies
9.4. Retail Pharmacies
9.5. Specialty Clinics
9.5.1. Community Health Centers
9.5.2. Infectious Disease Clinics
10. Parenteral PrEP Market, by End Users
10.1. Introduction
10.2. Community Health Centers
10.2.1. Rural Centers
10.2.2. Urban Centers
10.3. HIV Clinics
10.4. Research Centers
10.4.1. Academic Institutions
10.4.2. Private Research Organizations
11. Parenteral PrEP Market, by Regimen
11.1. Introduction
11.2. On-Demand Dosing
11.3. Periodic Dosing
12. Parenteral PrEP Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Parenteral PrEP Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Parenteral PrEP Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Accord Healthcare Inc.
16.2. Amneal Pharmaceuticals, Inc.
16.3. Aurobindo Pharma Ltd.
16.4. Cipla Ltd.
16.5. Dr. Reddy's Laboratories Ltd.
16.6. Fresenius Kabi AG
16.7. Gilead Sciences, Inc.
16.8. Hetero Labs Limited
16.9. Lupin Limited
16.10. Merck & Co., Inc.
16.11. Mylan N.V.
16.12. Sun Pharmaceutical Industries Ltd.
16.13. Teva Pharmaceutical Industries Ltd.
16.14. Viatris Inc.
16.15. ViiV Healthcare Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Parenteral PrEP Market, Years Considered for the Study
FIGURE 2. Global Parenteral PrEP Market, Research Design
FIGURE 3. Global Parenteral PrEP Market, Research Framework
FIGURE 4. Global Parenteral PrEP Market, Data Triangulation
FIGURE 5. Global Parenteral PrEP Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Parenteral PrEP Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Parenteral PrEP Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Parenteral PrEP Market Size, by Molecule Type, 2025 vs 2032 (%)
FIGURE 9. Global Parenteral PrEP Market Size, by Molecule Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Parenteral PrEP Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Parenteral PrEP Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Parenteral PrEP Market Size, by End Users, 2025 vs 2032 (%)
FIGURE 13. Global Parenteral PrEP Market Size, by End Users, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Parenteral PrEP Market Size, by Regimen, 2025 vs 2032 (%)
FIGURE 15. Global Parenteral PrEP Market Size, by Regimen, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Parenteral PrEP Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Parenteral PrEP Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Parenteral PrEP Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Parenteral PrEP Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Parenteral PrEP Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Parenteral PrEP Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Parenteral PrEP Market Segmentation & Coverage
TABLE 2. Global Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 3. Global Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Implantable Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Implantable Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Implantable Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Biodegradable Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Biodegradable Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Biodegradable Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Non-Biodegradable Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Non-Biodegradable Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Non-Biodegradable Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Long-Acting Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Long-Acting Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Long-Acting Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cabotegravir Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cabotegravir Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cabotegravir Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Lenacapavir Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Lenacapavir Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Lenacapavir Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Prefilled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Prefilled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Prefilled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 26. Global Cabotegravir Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Cabotegravir Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Cabotegravir Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Lenacapavir Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Lenacapavir Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Lenacapavir Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 33. Global Direct-To-Patient Programs Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Direct-To-Patient Programs Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Direct-To-Patient Programs Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Home Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Home Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Home Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Mail Order Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Mail Order Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Mail Order Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Community Health Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Community Health Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Community Health Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Infectious Disease Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Infectious Disease Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Infectious Disease Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 58. Global Community Health Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Community Health Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Community Health Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Rural Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Rural Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Rural Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Urban Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Urban Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Urban Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global HIV Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global HIV Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global HIV Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Research Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Research Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Research Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Private Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Private Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Private Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 80. Global On-Demand Dosing Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global On-Demand Dosing Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global On-Demand Dosing Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Periodic Dosing Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Periodic Dosing Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Periodic Dosing Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 99. North America Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. North America Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. North America Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 102. North America Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 103. North America Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 104. North America Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. North America Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 106. North America Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 107. North America Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 108. North America Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 109. North America Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 110. North America Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 111. Latin America Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Latin America Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Latin America Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 114. Latin America Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 115. Latin America Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 116. Latin America Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Latin America Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 118. Latin America Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 119. Latin America Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 120. Latin America Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 121. Latin America Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 122. Latin America Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 123. Europe Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Europe Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Europe Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 126. Europe Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 127. Europe Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 128. Europe Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Europe Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 130. Europe Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 131. Europe Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 132. Europe Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 133. Europe Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 134. Europe Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 135. Middle East Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Middle East Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. Middle East Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 138. Middle East Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 139. Middle East Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 140. Middle East Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Middle East Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 142. Middle East Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 143. Middle East Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 144. Middle East Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 145. Middle East Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 146. Middle East Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 147. Africa Parenteral PrEP Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Africa Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Africa Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 150. Africa Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 151. Africa Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 152. Africa Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Africa Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 154. Africa Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 155. Africa Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 156. Africa Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 157. Africa Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 158. Africa Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 159. Global Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. ASEAN Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. ASEAN Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. ASEAN Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 163. ASEAN Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 164. ASEAN Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 165. ASEAN Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. ASEAN Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 167. ASEAN Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 168. ASEAN Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 169. ASEAN Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 170. ASEAN Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 171. ASEAN Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 172. GCC Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. GCC Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. GCC Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 175. GCC Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 176. GCC Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 177. GCC Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. GCC Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 179. GCC Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 180. GCC Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 181. GCC Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 182. GCC Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 183. GCC Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 184. European Union Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. European Union Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. European Union Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 187. European Union Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 188. European Union Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 189. European Union Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. European Union Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 191. European Union Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 192. European Union Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 193. European Union Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 194. European Union Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 195. European Union Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 196. BRICS Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. BRICS Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. BRICS Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 199. BRICS Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 200. BRICS Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 201. BRICS Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. BRICS Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 203. BRICS Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 204. BRICS Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 205. BRICS Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 206. BRICS Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 207. BRICS Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 208. G7 Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. G7 Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. G7 Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 211. G7 Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 212. G7 Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 213. G7 Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. G7 Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 215. G7 Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 216. G7 Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 217. G7 Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 218. G7 Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 219. G7 Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 220. NATO Parenteral PrEP Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. NATO Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. NATO Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 223. NATO Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 224. NATO Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 225. NATO Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. NATO Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 227. NATO Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 228. NATO Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 229. NATO Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 230. NATO Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 231. NATO Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 232. Global Parenteral PrEP Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. United States Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 234. United States Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. United States Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 236. United States Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 237. United States Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 238. United States Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. United States Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 240. United States Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 241. United States Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 242. United States Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 243. United States Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 244. United States Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 245. Canada Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 246. Canada Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. Canada Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 248. Canada Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 249. Canada Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 250. Canada Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. Canada Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 252. Canada Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 253. Canada Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 254. Canada Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 255. Canada Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 256. Canada Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 257. Mexico Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 258. Mexico Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. Mexico Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 260. Mexico Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 261. Mexico Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 262. Mexico Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. Mexico Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 264. Mexico Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 265. Mexico Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 266. Mexico Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 267. Mexico Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 268. Mexico Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 269. Brazil Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 270. Brazil Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. Brazil Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 272. Brazil Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 273. Brazil Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 274. Brazil Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Brazil Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 276. Brazil Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 277. Brazil Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 278. Brazil Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 279. Brazil Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 280. Brazil Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 281. United Kingdom Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 282. United Kingdom Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. United Kingdom Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 284. United Kingdom Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 285. United Kingdom Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 286. United Kingdom Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 287. United Kingdom Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 288. United Kingdom Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 289. United Kingdom Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 290. United Kingdom Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 291. United Kingdom Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 292. United Kingdom Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 293. Germany Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 294. Germany Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 295. Germany Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 296. Germany Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 297. Germany Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 298. Germany Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 299. Germany Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 300. Germany Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 301. Germany Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 302. Germany Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 303. Germany Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 304. Germany Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 305. France Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 306. France Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 307. France Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 308. France Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 309. France Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 310. France Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 311. France Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 312. France Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 313. France Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 314. France Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 315. France Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 316. France Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 317. Russia Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 318. Russia Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. Russia Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 320. Russia Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 321. Russia Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 322. Russia Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. Russia Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 324. Russia Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 325. Russia Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 326. Russia Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 327. Russia Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 328. Russia Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 329. Italy Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 330. Italy Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 331. Italy Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 332. Italy Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 333. Italy Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 334. Italy Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 335. Italy Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 336. Italy Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 337. Italy Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 338. Italy Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 339. Italy Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 340. Italy Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 341. Spain Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 342. Spain Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 343. Spain Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 344. Spain Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 345. Spain Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 346. Spain Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. Spain Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 348. Spain Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 349. Spain Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 350. Spain Parenteral PrEP Market Size, by Community Health Centers, 2017-2032 (USD Million)
TABLE 351. Spain Parenteral PrEP Market Size, by Research Centers, 2017-2032 (USD Million)
TABLE 352. Spain Parenteral PrEP Market Size, by Regimen, 2017-2032 (USD Million)
TABLE 353. China Parenteral PrEP Market Size, 2017-2032 (USD Million)
TABLE 354. China Parenteral PrEP Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 355. China Parenteral PrEP Market Size, by Implantable Device, 2017-2032 (USD Million)
TABLE 356. China Parenteral PrEP Market Size, by Long-Acting Injectable, 2017-2032 (USD Million)
TABLE 357. China Parenteral PrEP Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 358. China Parenteral PrEP Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 359. China Parenteral PrEP Market Size, by Direct-To-Patient Programs, 2017-2032 (USD Million)
TABLE 360. China Parenteral PrEP Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 361. China Parenteral PrEP Market Size, by End Users, 2017-2032 (USD Million)
TABLE 362. China Parenteral PrEP Market Size, by Community Health Ce

Companies Mentioned

  • Accord Healthcare Inc.
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Fresenius Kabi AG
  • Gilead Sciences, Inc.
  • Hetero Labs Limited
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • ViiV Healthcare Limited

Related Topics

Related Reports

Drugs for PrEP Market - Global Forecast 2026-2032 - Product Image

Drugs for PrEP Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Pharmaceutical Sample Preprocessing System Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Sample Preprocessing System Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Parenteral Nutrition - Global Strategic Business Report - Product Image

Parenteral Nutrition - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type, Stage Type, Indication, Sales Channel, Region, and Growth Forecasts, 2026-2033 - Product Image

Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type, Stage Type, Indication, Sales Channel, Region, and Growth Forecasts, 2026-2033

  • Report
  • 190 Pages
  • Global
From
Vitamin D Therapy - Global Strategic Business Report - Product Image

Vitamin D Therapy - Global Strategic Business Report

  • Report
  • 222 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.